发明名称 |
Prodefensin-A6 assay method for the in vitro diagnosis of colorectal cancer |
摘要 |
The present invention relates to a method for the in vitro diagnosis of colorectal cancer by determining the presence of the Prodefensin-A6 tumour marker in a biological sample taken from a patient suspected of having colorectal cancer, it being possible for said method to be used both in early diagnosis, screening, therapeutic follow-up and prognosis, and in relapse diagnosis in relation to colorectal cancer. |
申请公布号 |
US9062099(B2) |
申请公布日期 |
2015.06.23 |
申请号 |
US201013260854 |
申请日期 |
2010.04.01 |
申请人 |
BIOMERIEUX |
发明人 |
Ataman-Önal Yasemin;Beaulieu Corinne;Busseret Sandrine;Charrier Jean-Philippe;Choquet-Kastylevsky Geneviève;Rolland Dominique |
分类号 |
G01N33/53;C07K16/18;C07K16/30;G01N33/574 |
主分类号 |
G01N33/53 |
代理机构 |
Oliff PLC |
代理人 |
Oliff PLC |
主权项 |
1. An in vitro method for diagnosing colorectal cancer using a biological sample obtained from a patient suspected of having colorectal cancer, comprising:
assaying for the level of the Prodefensin-A6 protein present in the biological sample using at least one antibody or antibody fraction specific for the Prodefensin-A6 protein; and determining whether the level of the Prodefensin-A6 protein is indicative of the patient having colorectal cancer, wherein the level of the Prodefensin-A6 protein is assayed by detecting any of the signal peptide or the propeptide of the Prodefensin-A6 protein, whether as part of the intact Prodefensin-A6 protein or a fragment thereof, to the exclusion of the mature Defensin-A6 protein or fragments of the mature Defensin-A6 protein. |
地址 |
Marcy l'Etoile FR |